Citywire for Financial Professionals

Syncona (Ordinary Share) SYNC

Sector Specialist: Biotechnology/Life Sciences

Register or Sign in to receive email alerts for items in your favourites whenever we write about them

Add to Virtual Portfolio | Print page

Estimated NAV

155.00

Share Price

212.50

Total Returns on £1000 over 

Fund / Benchmark Total returns(%)
Syncona (Ordinary Share) Price 87.87%
Syncona (Ordinary Share) NAV 38.51%
FTSE World 54.87%
Total Returns on £1000

Discount / Premium Movement

Discount / Premium Movement

Shares

Share Type Yesterday's
Closing Price
Discount / Premium Diluted NAV Gearing Dividend
Est Last
Ordinary Share 213.5 37.8% 155.00 155.00
30 Nov
100% 1.03%

Discrete performance % over

Fund / BenchmarkFeb '15
Jan '16
Feb '16
Jan '17
Feb '17
Jan '18
Syncona (Ordinary Share) Price6.794.5368.31
Syncona (Ordinary Share) NAV1.7116.6116.78
FTSE World-2.8443.6110.98

Discrete performance over

Discrete Performance

Top 10 Holdings

Polygon European Equity Opportunity Fund 4.95%
Polar Capital Japan Alpha Fund 4.62%
The SFP Value Realization Fund 4.19%
Polar UK Absolute Equity Fund 3.98%
Majedie Asset UK Equity 3.87%
Parity Value Fund 3.87%
Maga Smaller Companies Fund 3.44%
AKO Global UCITS Fund 3.33%
Sinfonietta Fund 3.01%
Portland Hill 2.90%

Sectors weighting

Life Science 32.00%
Equity Hedge 26.00%
Equity Non- Hedge 17.00%
Cash/Cash Equivalent 7.00%
Macro 6.00%
Credit 6.00%
Unlisted Equities 3.00%
Fixed Interest 2.00%
Infrastructure 1.00%
  • Investment trust info:

  • Sector Sector Specialist: Biotechnology/Life Sciences
  • Launch Date 26 Oct 2012
  • Currency GBX
  • Domicile Guernsey
  • Share Price 212.50
  • Share Type Ordinary Share
  • TIDM SYNC
  • ISIN GG00B8P59C08
  • Shares Issued (M) 660
  • Market Capital (£M) 1409.00
  • Gross Assets (£M) 1022.86
  • Net Assets (£M) 1022.86
  • TER (%) 1.27
  • Historic Dividend Yield (%) 1.03
  • Last AGM 08 Sep 2017
  • Next AGM 10 Sep 2018
  • Last Annual Report Date 01 Aug 2016
  • Next due Report Date 31 Mar 2017
  • Next due Report Type A/R
  • Objective:

  • To deliver superior returns from investments in life science businesses, leading long-only and alternative investment funds across multiple asset classes.
  • Management Group(s):

  • BACIT Investments LP
  • Syncona Investment Management Limited
  • Managed by:

  • Fenella Dernie Start: 26 Oct 2012
  • John McDonald Start: 26 Oct 2012
  • Thomas Henderson Start: 26 Oct 2012
  • Management Contract & Fees:

    BACIT (UK) Limited is the Company's Investment Manager. The operating expenses of the Investment Manager are covered by a Management Expense Contribution, payable by the Company to the Investment Manager, equal to 0.19% of p.a. of NAV.

Sorry, this link is not
quite ready yet